cerebral adrenoleukodystrophy (cald)
Showing 1 - 4 of 4
Cerebral Adrenoleukodystrophy (cALD) Trial in Argentina, Brazil, United States (Leriglitazone, Placebo)
Not yet recruiting
- Cerebral Adrenoleukodystrophy (cALD)
- Leriglitazone
- Placebo
-
Palo Alto, California
- +6 more
Apr 5, 2023
Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug
Enrolling by invitation
- Cerebral Adrenoleukodystrophy (CALD)
- +2 more
- Lenti-D
-
Los Angeles, California
- +10 more
Nov 4, 2022
Cerebral Adrenoleukodystrophy (CALD) Trial in Worldwide (Lenti-D Drug Product (eli-cel))
Completed
- Cerebral Adrenoleukodystrophy (CALD)
- Lenti-D Drug Product (eli-cel)
-
Los Angeles, California
- +7 more
Mar 25, 2022
Cerebral Adrenoleukodystrophy (CALD) Trial in Worldwide (Lenti-D)
Active, not recruiting
- Cerebral Adrenoleukodystrophy (CALD)
- Lenti-D
-
Palo Alto, California
- +7 more
Mar 22, 2022